AnazaoHealth Corporation recalls B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML S…
- Recall date
- November 22, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0203-2024
- FDA classification
- Class II
- Brand / firm
- AnazaoHealth Corporation
- Sold / distributed
- Nationwide in the USA.
Why it was recalled
Presence of Particulate Matter.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
B-Complex, Thiamine HCI / Riboflavin / Niacinamide / Dexpanthenol / Pyridoxine HCI injection, 74/2/75/2/2 MG/ML, 30ML Sterile Multiple-Dose Vial, Rx only, AnazaoHealth, 7465 W Sunset Rd #1200, Las Vegas, NV 89113, NDC 72682-2230-3
Get recall alerts
Free email alert whenever AnazaoHealth Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: AnazaoHealth Corporation